Goal prioritization and behavior change: Evaluation of an intervention for multiple health behaviors.


Journal

Health psychology : official journal of the Division of Health Psychology, American Psychological Association
ISSN: 1930-7810
Titre abrégé: Health Psychol
Pays: United States
ID NLM: 8211523

Informations de publication

Date de publication:
May 2022
Historique:
entrez: 25 4 2022
pubmed: 26 4 2022
medline: 28 4 2022
Statut: ppublish

Résumé

Goal prioritization is a promising strategy for promoting health behavior change. The present research (a) tested whether goal prioritization engenders change in multiple health behaviors, (b) compared the effectiveness of prioritizing one versus two health behavior goals, and (c) assessed whether prioritization compromises the performance of nonprioritized behaviors. Participants (N = 1,802) were randomly allocated to one of two intervention conditions (prioritize one vs. two behaviors) or two no-prioritization, control conditions. Participants in the intervention conditions self-selected the behavior(s) to prioritize from a given set. Goal priority and behavioral performance were assessed 8 weeks later. The prioritization interventions were successful in promoting goal priority and led to significantly greater behavior change compared to both control conditions. Prioritizing two health behavior goals led to increased behavioral performance compared to prioritizing a single goal. Goal prioritization did not lead to a decline in rates of performance of nonprioritized behaviors. The present findings offer new evidence that goal prioritization is effective in promoting health behavior change. Prioritizing health goals engenders behavior change for both one and two focal behaviors and does so without adversely affecting the performance of nonprioritized health behaviors. Further tests of interventions to promote the priority of health goals are warranted. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Identifiants

pubmed: 35467903
pii: 2022-56233-003
doi: 10.1037/hea0001149
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

356-365

Subventions

Organisme : Unilever Research

Auteurs

Mark Conner (M)

School of Psychology, University of Leeds.

Sarah Wilding (S)

School of Psychology, University of Leeds.

Andrew Prestwich (A)

School of Psychology, University of Leeds.

Russell Hutter (R)

School of Psychology, University of Leeds.

Frenk van Harreveld (FV)

University of Amsterdam.

Charles Abraham (C)

School of Psychology, Deakin University.

Paschal Sheeran (P)

Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH